-
The FDA has approved the first transbuccal delivery system for testosterone replacement therapy in men.
-
Dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimers disease.
-
Current users of estrogen or estrogen-progestin combinations were shown to have a significantly higher risk of developing and dying from breast cancer. The findings confirm and extend those published last year by the Womens Health Initiative.
-
This study demonstrated that the Stretta endoscopic radiofrequency application technique for treatment of gastroesophageal reflux disease did lead to lessened GERD-related symptoms but not to any decrease in esophageal acid exposure or medication use.
-
-
Urinary Tetrahydroaldosterone as a Screen for Primary Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed Covers in Patients with Allergic Rhinitis
-
Dizziness and vertigo are among the most common complaints seen by neurologists, and benign paroxysmal positional vertigo is one of their most frequent causes.
-
Prognostic Value of ABPMs in patients with Treated Hypertension; Tazarotene Cream in the Treatment of Psoriasis; Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes; Metformin and Thiazolidinedione Use in Medicare Patients with Heart Failure; Alcohol Consumption Patterns and Biologic Markers of Glycemic Control; Azelaic Acid Gel as a New Treatment for Papulopustular Rosacea
-
-
Based on a patients lipoprotein abnormality, the algorithm described in this review begins with achievable, practical therapeutic lifestyle changes and then adds pharmacologic agents in stepwise fashion to address abnormalities of LDL cholesterol, triglycerides, and HDL cholesterol. While the approach is aggressive, it is not based on driving lipid levels to extremely low levels. While some of the lipid targets appear less stringent than conventional wisdom would suggest (eg, accepting an LDL cholesterol target of 130 mg/dL), the approach is in compliance with the spirit and letter of national guidelines.